Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Director/PDMR Shareholding

7 Dec 2006 07:02

ReNeuron Group plc07 December 2006 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or ReNeuron Group plc (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) Notification under (ii) above. 3. Name of person discharging managerial 4. State whether notification relates to a person responsibilities/director connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person Trevor Jones, Director N/A 5. Indicate whether the notification is in respect 6. Description of shares (including class), of a holding of the person referred to in 3 or 4 debentures or derivatives or financial above or in respect of a non-beneficial interest instruments relating to shares 1 Beneficial Interest Ordinary Shares 7. Name of registered shareholders(s) and, if more 8. State the nature of the transaction than one, the number of shares held by each of them Purchase Trevor Jones 9. Number of shares, debentures or financial 10. Percentage of issued class acquired (treasury instruments relating to shares acquired shares of that class should not be taken into account when calculating percentage) 25,700 shares 0.03% 11. Number of shares, debentures or financial 12. Percentage of issued class disposed (treasury instruments relating to shares disposed shares of that class should not be taken into account when calculating percentage) N/A N/A 13. Price per share or value of transaction 14. Date and place of transaction 19.5p per share 6 December 2006, England 15. Total holding following notification and total 16. Date issuer informed of transaction percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 6 December 2006 83,200 shares If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17. Date of grant 18. Period during which or date on which it can be exercised 19. Total amount paid (if any) for grant of the 20. Description of shares or debentures involved option (class and number) 21. Exercise price (if fixed at time of grant) or 22. Total number of shares or debentures over which indication that price is to be fixed at the time options held following notification of exercise 23. Any additional information 24. Name of contact and telephone number for queries Name and signature of duly authorised officer of issuer responsible for making notification __________________________________________________________ Date of notification _____________________________________ This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Jun 200912:17 pmRNSNotice of Results
12th Jun 20092:56 pmRNSHolding(s) in Company
9th Jun 20097:00 amRNSStem cells manufacturing contract signed
21st May 20098:43 amRNSHolding(s) in Company
19th May 20091:21 pmRNSHolding(s) in Company
19th May 20091:18 pmRNSHolding(s) in Company
18th May 20091:06 pmRNSHolding(s) in Company
18th May 20097:00 amRNSFinal Closing of the Placing
14th May 20093:02 pmRNSThird Closing Of The Placing
14th May 200910:43 amRNSRegulatory update
1st May 20097:00 amRNSReN001 data to be presented at US conference
9th Apr 20097:00 amRNSSuccessful automation of stem cell manufacturing
8th Apr 20099:51 amRNSHolding(s) in Company
8th Apr 20099:43 amRNSHolding(s) in Company
7th Apr 20097:00 amRNSSecond Closing of the Placing
6th Apr 20097:00 amRNSPositive pre-clinical data with CTX stem cell line
3rd Apr 200911:19 amRNSResult of EGM and First Closing of the Placing
12th Mar 20097:00 amRNSAnnounces Fundraising and Conversion of Loan Notes
24th Feb 20094:03 pmRNSHolding(s) in Company
26th Jan 20097:00 amRNSReNeuron licenses stem cell line to BioFocus DPI
21st Jan 20097:00 amRNSReNeuron clarifies press comments
19th Jan 20094:00 pmRNSUpdate on ReNeuron's clinical trial
19th Jan 20097:00 amRNSReNeuron gains approval to commence trial
28th Nov 20087:00 amRNSInterim Results
24th Nov 20087:00 amRNSAppointment of NED
14th Nov 20083:30 pmRNSResearch Update
19th Sep 200810:46 amRNSResult of AGM
19th Sep 20087:00 amRNSAGM Statement
7th Aug 20083:33 pmRNSAnnual Report and Accounts
15th Jul 20087:00 amRNSResearch Update
24th Jun 20087:00 amRNSFinal Results
24th Jun 20087:00 amRNSRe: Fund Raising
23rd Jun 20083:38 pmRNSHolding(s) in Company
19th Jun 20084:33 pmRNSNotice of Results
11th Jun 20087:00 amRNSRe: ISSCR Conference
29th May 20087:00 amRNSRe: Contract
21st May 20087:00 amRNSNotice of US Patent Grant
20th May 200810:46 amRNSRe: UK Government Vote
23rd Apr 20087:00 amRNSResearch Update
19th Mar 20087:00 amRNSRegulatory Update
1st Feb 20087:01 amRNSResearch Update
7th Jan 20081:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20081:28 pmRNSRegulatory Update
11th Dec 20077:00 amRNSTo Present at Conference
28th Nov 200711:25 amRNSTo Present at US Conference
28th Nov 200711:13 amRNSNotice of Results
21st Nov 200711:30 amRNSResearch Update
8th Nov 20077:30 amRNSContract with ReNeuron
18th Oct 20077:01 amRNSResearch Update
6th Sep 200711:12 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.